Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noushin Nabavi

Showing results (21-30 of 94) with videos related to

Pageof 10
Sort By:
Molecular Cancer|October 10, 2025
Advances in RNA-based cancer therapeutics: pre-clinical and clinical implicationsYubo Yan, Shuang Liu, Jie Wen, et al.
Pathology, Research and Practice|April 2, 2025
Peptides in breast cancer therapy: From mechanisms to emerging drug delivery and immunotherapy strategiesElmira Alaei, Farid Hashemi, Najma Farahani, et al.
Non-Coding RNA Research|July 18, 2024
Ferroptosis contributes to the progression of female-specific neoplasms, from breast cancer to gynecological malignancies in a manner regulated by non-coding RNAs: Mechanistic implicationsKiavash Hushmandi, Daniel J Klionsky, Amir Reza Aref, et al.
Pathology, Research and Practice|December 22, 2023
Role of non-coding RNAs in osteoporosisMojtaba Baniasadi, Sina Talebi, Khatere Mokhtari, et al.
International Journal of Biological Macromolecules|March 13, 2026
STAT3-driven EMT in cancer metastasis and chemoresistance: A reviewYu Tian, Min Tang, Meng Qiao, et al.
Journal of Cell Communication and Signaling|December 18, 2024
Exploring the dual role of endoplasmic reticulum stress in urological cancers: Implications for tumor progression and cell death interactionsNajma Farahani, Mina Alimohammadi, Mehdi Raei, et al.
Cytokine & Growth Factor Reviews|May 28, 2025
TGF-β-driven EMT in cancer progression and drug resistanceWen Luo, Qingfeng Shi, Mingming Han, et al.
International Journal of Cancer|February 15, 2018
Aneustat (OMN54) has aerobic glycolysis-inhibitory activity and also immunomodulatory activity as indicated by a first-generation PDX prostate cancer modelSifeng Qu, Hui Xue, Xin Dong, et al.
Pathology, Research and Practice|July 17, 2024
The function and mechanism of circRNAs in 5-fluorouracil resistance in tumors: Biological mechanisms and future potentialAlireza Mafi, Neda Hedayati, Yaser Eshaghi Milasi, et al.
Pathology, Research and Practice|April 4, 2025
Harnessing immunotherapy for hepatocellular carcinoma: Principles and emerging promisesHossein Miri, Payman Rahimzadeh, Mehrdad Hashemi, et al.
Pageof 10

Showing results (21-30 of 94) with videos related to

Sort By:
Pageof 10
Molecular Cancer|October 10, 2025
Advances in RNA-based cancer therapeutics: pre-clinical and clinical implicationsYubo Yan, Shuang Liu, Jie Wen, et al.
Pathology, Research and Practice|April 2, 2025
Peptides in breast cancer therapy: From mechanisms to emerging drug delivery and immunotherapy strategiesElmira Alaei, Farid Hashemi, Najma Farahani, et al.
Non-Coding RNA Research|July 18, 2024
Ferroptosis contributes to the progression of female-specific neoplasms, from breast cancer to gynecological malignancies in a manner regulated by non-coding RNAs: Mechanistic implicationsKiavash Hushmandi, Daniel J Klionsky, Amir Reza Aref, et al.
Pathology, Research and Practice|December 22, 2023
Role of non-coding RNAs in osteoporosisMojtaba Baniasadi, Sina Talebi, Khatere Mokhtari, et al.
International Journal of Biological Macromolecules|March 13, 2026
STAT3-driven EMT in cancer metastasis and chemoresistance: A reviewYu Tian, Min Tang, Meng Qiao, et al.
Journal of Cell Communication and Signaling|December 18, 2024
Exploring the dual role of endoplasmic reticulum stress in urological cancers: Implications for tumor progression and cell death interactionsNajma Farahani, Mina Alimohammadi, Mehdi Raei, et al.
Cytokine & Growth Factor Reviews|May 28, 2025
TGF-β-driven EMT in cancer progression and drug resistanceWen Luo, Qingfeng Shi, Mingming Han, et al.
International Journal of Cancer|February 15, 2018
Aneustat (OMN54) has aerobic glycolysis-inhibitory activity and also immunomodulatory activity as indicated by a first-generation PDX prostate cancer modelSifeng Qu, Hui Xue, Xin Dong, et al.
Pathology, Research and Practice|July 17, 2024
The function and mechanism of circRNAs in 5-fluorouracil resistance in tumors: Biological mechanisms and future potentialAlireza Mafi, Neda Hedayati, Yaser Eshaghi Milasi, et al.
Pathology, Research and Practice|April 4, 2025
Harnessing immunotherapy for hepatocellular carcinoma: Principles and emerging promisesHossein Miri, Payman Rahimzadeh, Mehrdad Hashemi, et al.
Pageof 10